Manufacturers Life Insurance Company, The Biotechnology

Manufacturers Life Insurance Company, The

$100 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$123B	$265 Million 0.26% of portfolio	546,904	Q1 2025 Added 0.28%
REGN Regeneron Pharmaceuticals, Inc.	$59.2B	$253 Million 0.25% of portfolio	398,236	Q1 2025 Added 11.74%
BBIO Bridge Bio Pharma, Inc.	$6.82B	$65.3 Million 0.07% of portfolio	1,887,763	Q1 2025 Added 0.1%
JAZZ Jazz Pharmaceuticals PLC	$7B	$64 Million 0.06% of portfolio	515,407	Q1 2025 Added 45.81%
ARGX Argenx Se	$30.7B	$35.3 Million 0.04% of portfolio	59,694	Q1 2025 Reduced 3.89%
ALNY Alnylam Pharmaceuticals, Inc.	$39.5B	$26.7 Million 0.03% of portfolio	98,869	Q1 2025 Reduced 9.38%
INSM Insmed Inc	$13.1B	$24.3 Million 0.02% of portfolio	318,392	Q1 2025 Added 1.66%
UTHR United Therapeutics Corp	$13.7B	$22.1 Million 0.02% of portfolio	71,761	Q1 2025 Reduced 41.81%
HALO Halozyme Therapeutics, Inc.	$7.88B	$20.4 Million 0.02% of portfolio	320,017	Q1 2025 Added 12.73%
BPMC Blueprint Medicines Corp	$7.68B	$14.5 Million 0.01% of portfolio	164,055	Q1 2025 Reduced 7.04%
ZLAB Zai Lab LTD	$3.49B	$14.5 Million 0.01% of portfolio	401,082	Q1 2025 Added 150.09%
ACAD Acadia Pharmaceuticals Inc	$3.49B	$13.4 Million 0.01% of portfolio	804,119	Q1 2025 Added 28.04%
RPRX Royalty Pharma PLC	$15.7B	$13.3 Million 0.01% of portfolio	428,775	Q1 2025 Added 182.17%
BGNE Bei Gene, Ltd.	$23.5B	$12.8 Million 0.01% of portfolio	56,248	Q1 2025 Reduced 5.99%
SRPT Sarepta Therapeutics, Inc.	$1.7B	$12.6 Million 0.01% of portfolio	197,620	Q1 2025 Added 2.05%
ASND Ascendis Pharma A/S	$9.81B	$12.3 Million 0.01% of portfolio	79,132	Q1 2025 Reduced 4.61%
MRNA Moderna, Inc.	$12.8B	$11.1 Million 0.01% of portfolio	390,266	Q1 2025 Reduced 88.32%
TECH Bio Techne Corp	$2.06B	$10.9 Million 0.01% of portfolio	186,018	Q1 2025 Reduced 5.29%
RARE Ultragenyx Pharmaceutical Inc.	$2.9B	$10.6 Million 0.01% of portfolio	293,374	Q1 2025 Added 35.45%
BMRN Biomarin Pharmaceutical Inc	$11.1B	$9.84 Million 0.01% of portfolio	139,267	Q1 2025 Reduced 9.74%
INCY Incyte Corp	$15.3B	$9.66 Million 0.01% of portfolio	159,605	Q1 2025 Reduced 13.67%
SMMT Summit Therapeutics Inc.	$4.61B	$8.99 Million 0.01% of portfolio	466,164	Q1 2025 Reduced 2.23%
EXEL Exelixis, Inc.	$14.2B	$8.54 Million 0.01% of portfolio	231,380	Q1 2025 Reduced 2.52%
RVMD Revolution Medicines, Inc.	$3.38B	$8.49 Million 0.01% of portfolio	240,095	Q1 2025 Added 1.08%
VRNA Verona Pharma PLC	$5.49B	$7.92 Million 0.01% of portfolio	124,721	Q1 2025 Reduced 1.59%
RNA Avidity Biosciences, Inc.	$1.5B	$7.81 Million 0.01% of portfolio	264,513	Q1 2025 Added 0.08%
MDGL Madrigal Pharmaceuticals, Inc.	$5.28B	$7.6 Million 0.01% of portfolio	22,945	Q1 2025 Reduced 4.71%
SRRK Scholar Rock Holding Corp	$1.74B	$6.93 Million 0.01% of portfolio	215,405	Q1 2025 Added 1.26%
CYTK Cytokinetics Inc	$3.45B	$6.74 Million 0.01% of portfolio	167,684	Q1 2025 Reduced 11.06%
AKRO Akero Therapeutics, Inc.	$2.39B	$6.12 Million 0.01% of portfolio	151,290	Q1 2025 Added 21.43%
PTGX Protagonist Therapeutics, Inc	$2.45B	$5.84 Million 0.01% of portfolio	120,850	Q1 2025 Reduced 2.81%
KRYS Krystal Biotech, Inc.	$3.82B	$5.84 Million 0.01% of portfolio	32,366	Q1 2025 Reduced 8.07%
CORT Corcept Therapeutics Inc	$7.59B	$5.82 Million 0.01% of portfolio	50,977	Q1 2025 Added 2.45%
PCVX Vaxcyte, Inc.	$2.12B	$5.78 Million 0.01% of portfolio	153,152	Q1 2025 Reduced 3.39%
ACLX Arcellx, Inc.	$2.94B	$5.7 Million 0.01% of portfolio	86,828	Q1 2025 Reduced 11.68%
MLTX Moon Lake Immunotherapeutics	$1.81B	$4.88 Million 0.0% of portfolio	124,904	Q1 2025 Reduced 12.47%
SWTX Spring Works Therapeutics, Inc.	$2.93B	$4.64 Million 0.0% of portfolio	105,217	Q1 2025 Reduced 74.19%
CRNX Crinetics Pharmaceuticals, Inc.	$1.74B	$4.52 Million 0.0% of portfolio	134,793	Q1 2025 Reduced 9.51%
CNTA Centessa Pharmaceuticals PLC	$1.28B	$4.35 Million 0.0% of portfolio	302,646	Q1 2025 Reduced 4.63%
NUVL Nuvalent, Inc.	$3.35B	$4.22 Million 0.0% of portfolio	59,449	Q1 2025 Added 22.9%
KYMR Kymera Therapeutics, Inc.	$2.47B	$3.9 Million 0.0% of portfolio	142,587	Q1 2025 Reduced 3.2%
AGIO Agios Pharmaceuticals, Inc.	$2.14B	$3.86 Million 0.0% of portfolio	131,571	Q1 2025 Added 7.76%
DNLI Denali Therapeutics Inc.	$2.01B	$3.51 Million 0.0% of portfolio	258,132	Q1 2025 Added 23.79%
RYTM Rhythm Pharmaceuticals, Inc.	$3.66B	$3.41 Million 0.0% of portfolio	64,386	Q1 2025 Added 7.37%
VERA Vera Therapeutics, Inc.	$619M	$3.4 Million 0.0% of portfolio	141,409	Q1 2025 Added 10.15%
ROIV Roivant Sciences Ltd.	$7.9B	$3.35 Million 0.0% of portfolio	331,802	Q1 2025 Reduced 1.84%
BEAM Beam Therapeutics Inc.	$1.51B	$3.33 Million 0.0% of portfolio	170,608	Q1 2025 Added 18.89%
TGTX Tg Therapeutics, Inc.	$5.23B	$3.2 Million 0.0% of portfolio	81,125	Q1 2025 Added 7.7%
TARS Tarsus Pharmaceuticals, Inc.	$1.07B	$2.87 Million 0.0% of portfolio	55,837	Q1 2025 Added 19.37%
IMCR Immunocore Holdings PLC	$1.52B	$2.82 Million 0.0% of portfolio	94,919	Q1 2025 Reduced 16.85%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.